New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease.

Wakeel H, Munir S, Gondal HY, Cheema ZM, Muskan A, Malik I, Nisar M, Siddiqui H, Sultan SK

DOI: 10.1039/d6ra06901k
Published: 2026 Nov 2
Container: RSC advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d6ra06901k,
  title = {New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease.},
  author = {Wakeel H and Munir S and Gondal HY and Cheema ZM and Muskan A and Malik I and Nisar M and Siddiqui H and Sultan SK},
  year = {2026},
  journal = {RSC advances},
  doi = {10.1039/d6ra06901k},
  url = {https://doi.org/10.1039/d6ra06901k}
}

RIS

TY  - JOUR
TI  - New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease.
AU  - Wakeel H
AU  - Munir S
AU  - Gondal HY
AU  - Cheema ZM
AU  - Muskan A
AU  - Malik I
AU  - Nisar M
AU  - Siddiqui H
AU  - Sultan SK
PY  - 2026
JO  - RSC advances
DO  - 10.1039/d6ra06901k
UR  - https://doi.org/10.1039/d6ra06901k
ER  -

APA

H, W., S, M., HY, G., ZM, C., A, M., I, M., M, N., H, S., & SK, S. (2026). New hemiaminal ether dihydropyrimidinones as CK1/CK2 inhibitors targeting α-synuclein in Parkinson's disease.. RSC advances. https://doi.org/10.1039/d6ra06901k

Source records

pubmed · retrieved 2026-11-10T08:46:48.782Z